Raymond James Financial Inc. bought a new stake in Genpact Limited (NYSE:G – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 129,261 shares of the business services provider’s stock, valued at approximately $5,552,000. Raymond James Financial Inc. owned 0.07% of Genpact as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its holdings in shares of Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after acquiring an additional 2,060,595 shares during the period. Tandem Investment Advisors Inc. grew its position in Genpact by 390.5% in the 4th quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock worth $91,480,000 after purchasing an additional 1,695,706 shares during the last quarter. Victory Capital Management Inc. increased its stake in shares of Genpact by 18.1% in the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider’s stock valued at $423,205,000 after purchasing an additional 1,511,790 shares during the period. Geode Capital Management LLC increased its stake in shares of Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after purchasing an additional 413,646 shares during the period. Finally, Empowered Funds LLC raised its holdings in shares of Genpact by 1,942.3% during the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider’s stock valued at $13,975,000 after buying an additional 309,447 shares during the last quarter. 96.03% of the stock is owned by institutional investors.
Genpact Trading Up 0.1 %
Shares of Genpact stock opened at $49.93 on Tuesday. The business has a fifty day simple moving average of $50.38 and a 200-day simple moving average of $44.78. The firm has a market cap of $8.77 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.
Genpact Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.36%. This is a boost from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio (DPR) is currently 23.94%.
Insiders Place Their Bets
In related news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.
Analyst Upgrades and Downgrades
G has been the subject of a number of recent analyst reports. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and increased their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and increased their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC raised their price target on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, Mizuho upped their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $48.44.
Read Our Latest Stock Report on G
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
- Five stocks we like better than Genpact
- Expert Stock Trading Psychology Tips
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What Are Dividends? Buy the Best Dividend Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.